MTOR and non-small cell lung carcinoma: Such NSCLC-derived CD39+ exosomes were sufficient to activate AMPK and suppress the mTOR in CD4+ T cells (Fig. 4E, F), which eventually reshaped T cell differentiation (Fig. 4G, S7C, D), mimicking the effect of NSCLC cells.